Prognostic value of circulating tumor cells in patients with pancreatic cancer: A meta-analysis

Tumor Biology

Volumn 35, Issue 3, 2014, Pages 2473-2480

  Han, Lu ^a   Chen, Wei ^b   Zhao, Qicheng ^c  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b TONGJI UNIVERSITY   (China)

^c TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Biomarker; Circulating tumor cells; Pancreatic cancer; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; ASIAN; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CAUCASIAN; CIRCULATING TUMOR CELL; ETHNICITY; HUMAN; OVERALL SURVIVAL; PANCREAS CANCER; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

DISEASE-FREE SURVIVAL; HUMANS; NEOPLASTIC CELLS, CIRCULATING; ODDS RATIO; PANCREATIC NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84899107449     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-013-1327-5     Document Type: Article

References (29)

1. Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an update. Dig Dis. 2010;28:645-56.
2. Raimondi S, Maisonneuve P, Lowenfels AB. Epidemiology of pancreatic cancer: an overview. Nat Rev Gastroenterol Hepatol. 2009;6:699-708.
3. Li D, Abbruzzese JL. New strategies in pancreatic cancer: emerging epidemiologic and therapeutic concepts. Clin Cancer Res. 2010;16:4313-8.
4. Lucas AL, Chang MM, Lipsyc MD, Frucht H. The prevention and genetics of pancreatic cancer: a programmatic approach. Methods Mol Biol. 2013;980:205-14.
5. Pantel K, Alix-Panabieres C. Circulating tumour cells in cancer patients: challenges and perspectives. Trends Mol Med. 2010;16:398-406.
6. Khoja L, Backen A, Sloane R, Menasce L, Ryder D, et al. A pilot study to explore circulating tumour cells in pancreatic cancer as a novel biomarker. Br J Cancer. 2012;106:508-16.
7. Coghlin C, Murray GI. Current and emerging concepts in tumour metastasis. J Pathol. 2010;222:1-15.
8. Nguyen DX, Bos PD, Massague J. Metastasis: from dissemination to organ-specific colonization. Nat Rev Cancer. 2009;9:274-84.
9. Bidard FC, Huguet F, Louvet C, Mineur L, Bouche O, et al. Circulating tumor cells in locally advanced pancreatic adenocarcinoma: the ancillary CirCe 07 study to the LAP 07 trial. Ann Oncol. 2013;24:2057-61.
10. de Albuquerque A, Kubisch I, Breier G, Stamminger G, Fersis N, et al. Multimarker gene analysis of circulating tumor cells in pancreatic cancer patients: a feasibility study. Oncology. 2012;82:3-10.
11. Hu L, Zhou JH, Yu ZQ, Yi YX, Ding H, et al. [Clinical significance of h-TERT and c-Met expression in the peripheral blood circulation of pancreatic cancer patients]. Chinese J Clin Oncol. 2013;40:208-11.
12. Soeth E, Grigoleit U, Moellmann B, Roder C, Schniewind B, et al. Detection of tumor cell dissemination in pancreatic ductal carcinoma patients by CK 20 RT-PCR indicates poor survival. J Cancer Res Clin Oncol. 2005;131:669-76.
13. Uchikura K, Takao S, Nakajo A, Miyazono F, Nakashima S, et al. Intraoperative molecular detection of circulating tumor cells by reverse transcription-polymerase chain reaction in patients with biliary-pancreatic cancer is associated with hematogenous metastasis. Ann Surg Oncol. 2002;9:364-70.
14. Stang A. Critical evaluation of the newcastle-ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603-5.
15. Jackson D, White IR, Riley RD. Quantifying the impact of between-study heterogeneity in multivariate meta-analyses. Stat Med. 2012;31:3805-20.
16. Biggerstaff BJ, Jackson D. The exact distribution of Cochran's heterogeneity statistic in one-way random effects meta-analysis. S Stat Med. 2008;27:6093-110.
17. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. JAMA. 2006;295:676-80.
18. Hirooka S, Yanagimoto H, Satoi S, Yamamoto T, Toyokawa H, et al. The role of circulating dendritic cells in patients with unresectable pancreatic cancer. Anticancer Res. 2011;31:3827-34.
19. Kurihara T, Itoi T, Sofuni A, Itokawa F, Tsuchiya T, et al. Detection of circulating tumor cells in patients with pancreatic cancer: a preliminary result. J Hepatobiliary Pancreat Surg. 2008;15:189-95.
20. Sergeant G, Roskams T, van Pelt J, Houtmeyers F, Aerts R, et al. Perioperative cancer cell dissemination detected with a real-time RT-PCR assay for EpCAM is not associated with worse prognosis in pancreatic ductal adenocarcinoma. BMC Cancer. 2011;11:47.
21. Riethdorf S, Fritsche H, Muller V, Rau T, Schindlbeck C, et al. Detection of circulating tumor cells in peripheral blood of patients with metastatic breast cancer: a validation study of the Cell Search system. Clin Cancer Res. 2007;13:920-8.
22. Cristofanilli M, Budd GT, Ellis MJ, Stopeck A, Matera J, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med. 2004;351:781-91.
23. Hou JM, Greystoke A, Lancashire L, Cummings J, Ward T, et al. Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapy. Am J Pathol. 2009;175:808-16.
24. Sequist LV, Nagrath S, Toner M, Haber DA, Lynch TJ. The CTC-chip: an exciting new tool to detect circulating tumor cells in lung cancer patients. J Thorac Oncol. 2009;4:281-3.
25. Stott SL, Lee RJ, Nagrath S, Yu M, Miyamoto DT, et al. Isolation and characterization of circulating tumor cells from patients with localized and metastatic prostate cancer. Sci Transl Med. 2010;2:25ra23.
26. Cohen SJ, Punt CJ, Iannotti N, Saidman BH, Sabbath KD, et al. Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer. Ann Oncol. 2009;20:1223-9.
27. Nakamura S, Yagata H, Ohno S, Yamaguchi H, Iwata H, et al. Multi-center study evaluating circulating tumor cells as a surrogate for response to treatment and overall survival in metastatic breast cancer. Breast Cancer. 2010;17:199-204.
28. Maestro LM, Sastre J, Rafael SB, Veganzones SB, Vidaurreta M, et al. Circulating tumor cells in solid tumor in metastatic and localized stages. Anticancer Res. 2009;29:4839-43.
29. McGauran N, Wieseler B, Kreis J, Schuler YB, Kolsch H, et al. Reporting bias in medical research - a narrative review. Trials. 2010;11:37.